## **Core Concept**
Carbenicillin is an extended-spectrum penicillin antibiotic that is effective against Pseudomonas aeruginosa, among other bacteria. Pseudomonas infections can be challenging to treat due to the bacteria's intrinsic resistance to many antibiotics and its ability to develop resistance. Combination therapy is often used to enhance efficacy and prevent resistance.

## **Why the Correct Answer is Right**
The correct answer, an aminoglycoside, is frequently combined with carbenicillin in the treatment of Pseudomonas infections. Aminoglycosides, such as gentamicin, tobramycin, or amikacin, have a synergistic effect when used with carbenicillin. This combination works because carbenicillin, a beta-lactam antibiotic, disrupts cell wall synthesis in bacteria, while aminoglycosides interfere with protein synthesis by binding to the bacterial 30S ribosomal subunit. This dual action can enhance bacterial killing, particularly in serious infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other antibiotics could potentially be used in combination for various infections, the specific synergy and common practice in treating Pseudomonas infections make this option less relevant.
- **Option B:** This option does not represent a commonly used antibiotic class in combination with carbenicillin for Pseudomonas infections.
- **Option C:** Similarly, this option does not accurately reflect a standard combination therapy for Pseudomonas infections.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the combination of a beta-lactam (like carbenicillin or piperacillin) with an aminoglycoside is a classic approach for treating severe Pseudomonas infections, such as pneumonia or bacteremia. However, the choice of antibiotics should always be guided by susceptibility testing and patient-specific factors.

## **Correct Answer:** .